Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy
暂无分享,去创建一个
[1] J. Ioannidis,et al. Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies , 2023, Journal of global health.
[2] Benjamin Cowling. The impact of ending ‘zero COVID’ in China , 2023, Nature Medicine.
[3] J. Wakefield,et al. The WHO estimates of excess mortality associated with the COVID-19 pandemic , 2022, Nature.
[4] G. Leung,et al. Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China , 2022, medRxiv.
[5] Yongdai Kim,et al. Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529) , 2022, BMC Medicine.
[6] M. Peiris,et al. Population-based sero-epidemiological estimates of real-world vaccine effectiveness against Omicron infection in an infection-naive population, Hong Kong, January to July 2022 , 2022, medRxiv.
[7] A. Nardone,et al. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies , 2022, PLoS medicine.
[8] D. Contopoulos-Ioannidis,et al. Age-stratified infection fatality rate of COVID-19 in the non-elderly population , 2022, Environmental Research.
[9] E. Lau,et al. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study , 2022, The Lancet Infectious Diseases.
[10] C. Anastassopoulou,et al. Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational study , 2022, The Lancet Regional Health - Europe.
[11] M. Ajelli,et al. Modeling transmission of SARS-CoV-2 Omicron in China , 2022, Nature Medicine.
[12] M. Levitt,et al. Comparison of pandemic excess mortality in 2020–2021 across different empirical calculations , 2022, Environmental Research.
[13] G. French,et al. Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic — United States, July 2020–July 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[14] J. Ioannidis. Over- and under-estimation of COVID-19 deaths , 2021, European Journal of Epidemiology.
[15] A. Pan,et al. Epidemiology and determinants of obesity in China. , 2021, The lancet. Diabetes & endocrinology.
[16] J. Ioannidis. Precision shielding for COVID-19: metrics of assessment and feasibility of deployment , 2020, BMJ Global Health.
[17] D. Asch,et al. Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic , 2020, JAMA internal medicine.
[18] Zhanlian Feng,et al. Long-term care system for older adults in China: policy landscape, challenges, and future prospects , 2020, The Lancet.
[19] L. Chow. Care homes and COVID-19 in Hong Kong: how the lessons from SARS were used to good effect , 2020, Age and ageing.
[20] D. Cummings,et al. Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries , 2020, medRxiv.
[21] D. Buckeridge,et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard , 2020, The Lancet Infectious Diseases.
[22] Alan D. Lopez,et al. Measuring the completeness of death registration in 2844 Chinese counties in 2018 , 2020, BMC Medicine.